CompletedPhase 2NCT02898012

Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status

Studying Glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Jean-Yves Delattre, MD-PhD
Pôle MSN, Groupe Hospitalier Pitié-Salpêtrière
Intervention
Temozolomide(drug)
Enrollment
70 target
Eligibility
70 years · All sexes
Timeline
2010 – 2013

Study locations (1)

Collaborators

Roche Pharma AG

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02898012 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma →

← Back to all trials